Diadexus, Inc. Stock

Stocks

DDXSQ

US25245P2056

Pharmaceuticals

OTC Markets Traded
Delayed 5-day change 1st Jan Change
- USD -.--% Intraday chart for Diadexus, Inc. -.--% -

Valuation: Diadexus, Inc.

Market Cap 49.2K 44.87K 41.31K 37.6K 70.55K 4.56M 74.38K 503K 200K 2.49M 185K 181K 7.8M P/E 2014
-3.26x
P/E 2015 -1.14x
Enterprise Value 5.29M 4.82M 4.44M 4.04M 7.59M 490M 8M 54.09M 21.48M 267M 19.85M 19.43M 839M EV / Sales 2014
1.05x
EV / Sales 2015 0.77x
Free-Float
100%
Yield 2014 *
-
Yield 2015 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 410
-0.30%-5.62%+28.35%+127.66% 1,204B
+1.25%-4.60%+33.56%+80.57% 643B
+0.94%-2.80%+22.88%+106.94% 501B
-0.60%-2.39%+27.92%+67.00% 378B
+0.69%-9.00%+40.68%+31.42% 327B
+0.41%-4.81%+24.99%+51.91% 285B
+0.81%-3.72%-1.35%+30.72% 270B
-0.15%-6.73%+27.23%+64.15% 237B
-0.06%-0.91%+29.95%+120.58% 207B
Average +0.37%-3.96%+26.02%+75.66% 405B
Weighted average by Cap. +0.46%-4.71%+27.25%+88.32%

Financials

2014 2015
Net sales 26.11M 23.81M 21.92M 19.95M 37.44M 2.42B 39.47M 267M 106M 1.32B 97.96M 95.9M 4.14B 17.88M 16.31M 15.01M 13.67M 25.64M 1.66B 27.04M 183M 72.62M 903M 67.09M 65.68M 2.83B
Net income -8.47M -7.72M -7.11M -6.47M -12.14M -785M -12.8M -86.57M -34.38M -428M -31.76M -31.1M -1.34B -7.17M -6.53M -6.02M -5.48M -10.28M -664M -10.83M -73.27M -29.1M -362M -26.88M -26.32M -1.14B
Net Debt -198K -181K -166K -151K -284K -18.35M -299K -2.02M -804K -10M -743K -727K -31.39M 5.24M 4.78M 4.4M 4.01M 7.52M 486M 7.92M 53.59M 21.28M 265M 19.66M 19.25M 831M
Logo Diadexus, Inc.
Diadexus, Inc. is a diagnostics company. The Company is engaged in developing and commercializing products that deliver healthcare providers with relevant information to assist in the management of patients throughout the course of cardiac disease. Its capabilities include manufacturing, assay development, Food and Drug Administration (FDA) regulatory clearance, and marketing and selling products. Its commercially-available products consist of two FDA-cleared tests to measure Lp-PLA2: the PLAC Test ELISA Kit (the PLAC ELISA Test) and the PLAC Test for Lp-PLA2 Activity (the PLAC Activity Test). Its other products include proADM; proET-1, which aids in predication of heart failure, and proANP, which aids in predication of heart failure. The Company sells its diagnostic products to laboratories and promotes these products to the laboratories' sales representatives, as well as directly to healthcare providers.
Employees
-
  1. Stock Market
  2. Stocks
  3. DDXSQ Stock